Part of a series of discussions by the Waggoner Center for Alcohol and Addiction Research about the neuroscientific, genetic and social aspects of alcohol drinking and the development of Alcohol Use ...

CHARLESTON, South Carolina, USA, 17 December 2024 - In a comprehensive Genomic Press Interview published today in Brain Medicine, renowned neuroscientist Dr. Peter Kalivas reveals crucial insights ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

Researchers find that tirzepatide (Mounjaro) reduces alcohol consumption by 50% and prevents relapse by blunting the brain's reward system.

Scientists have uncovered a surprising connection between sugar metabolism and alcohol addiction, identifying a potential new therapeutic target for treating alcohol-associated liver disease (ALD) and ...

I’ve often commented that the distance between the addiction research community and the 12-Step community polarizes treatment and undermines creative collaboration. When the professional community ...

Over the past decade, glucagon-like peptide-1 receptor (GLP-1R) agonists have transformed the treatment of type 2 diabetes and obesity. Anti-diabetic drugs such as semaglutide and liraglutide not only ...

Semaglutide, the active ingredient behind blockbuster weight-loss drugs like Wegovy, is now at the center of a growing body of evidence suggesting it can sharply reduce alcohol consumption in people ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine ...